These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 672015)

  • 1. [New approach to the deposition of biologically active compounds in the body: an experimental study of the intracoronary administration of modified Sephadex].
    Chazov EI; Cherpachenko NM; Mazaev AV; Il'ina EV; Lebedev BS
    Kardiologiia; 1978 Jun; 18(6):19-23. PubMed ID: 672015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [State of the microcirculation in myocardial ischemia and its alterations after depositing bioresorbing microspheres of Sephadex in the coronary bed].
    Mazaev AV; Ginzburg EM; Serebriakova LI; Bankuzov VA
    Kardiologiia; 1979 Oct; 19(10):45-8. PubMed ID: 502168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction.
    Shell WE; Lavelle JF; Covell JW; Sobel BE
    J Clin Invest; 1973 Oct; 52(10):2579-90. PubMed ID: 4729051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion.
    Maroko PR; Carpenter CB; Chiariello M; Fishbein MC; Radvany P; Knostman JD; Hale SL
    J Clin Invest; 1978 Mar; 61(3):661-70. PubMed ID: 641147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.
    Shell WE; Kjekshus JK; Sobel BE
    J Clin Invest; 1971 Dec; 50(12):2614-25. PubMed ID: 5129313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of bioresolving preparations of immobilized fibrinolysin].
    Chazov EI; Mazaev AV; Torchilin VP; Lebedev BS; Il'ina EV
    Kardiologiia; 1977 Nov; 17(11):139-42. PubMed ID: 146106
    [No Abstract]   [Full Text] [Related]  

  • 7. Coronary artery reperfusion. II. Reduction of myocardial infarct size at 1 week after the coronary occlusion.
    Ginks WR; Sybers HD; Maroko PR; Covell JW; Sobel BE; Ross J
    J Clin Invest; 1972 Oct; 51(10):2717-23. PubMed ID: 5056664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The sequelae of transient myocardial ischemia in chronic experiments].
    Pozin VM; Skuratovskaia SG; Pocheptsova GA
    Fiziol Zh (1978); 1992; 38(2):19-25. PubMed ID: 1373693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, optimization, and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery.
    Meenach SA; Kim YJ; Kauffman KJ; Kanthamneni N; Bachelder EM; Ainslie KM
    Mol Pharm; 2012 Feb; 9(2):290-8. PubMed ID: 22149217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A canine portal hypertension model induced by intra-portal administration of Sephadex microsphere.
    Jin W; Deng L; Zhang Q; Lin D; Zhu J; Chen Y; Chen B; Li J
    J Gastroenterol Hepatol; 2010 Apr; 25(4):778-85. PubMed ID: 20492334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities of using ferromagnetic materials for targeted drug transport].
    Papisov MI; Samokhin GP; Smirnov MD; Torcholin VP; Smirnov VN
    Biull Eksp Biol Med; 1984 Sep; 98(9):372-4. PubMed ID: 6207870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of perhexiline on survival time and infarct size in experimental myocardial infarction.
    Daniell HB; Privitera PJ; Conradi SE; Gaffney TE
    J Pharmacol Exp Ther; 1977 Jan; 200(1):155-65. PubMed ID: 833755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of Mercurascan after coronary artery ligation in the dog.
    Málek I; Kolc J; Mrhová O; Urbanová D; Málek P
    Eur J Cardiol; 1980; 12(1):55-62. PubMed ID: 7439234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of temperature-increase rate on drug release characteristics of dextran microspheres prepared by emulsion solvent evaporation process.
    Miyazaki Y; Onuki Y; Yakou S; Takayama K
    Int J Pharm; 2006 Nov; 324(2):144-51. PubMed ID: 16828994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between epicardial ST-segment elevation and myocardial ischemic damage after experimental coronary artery occlusion in dogs.
    Heng MK; Singh BN; Norris RM; John MB; Elliot R
    J Clin Invest; 1976 Dec; 58(6):1317-26. PubMed ID: 993347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A minimally invasive model of myocardial infarction made by video-assisted thoracoscopic surgery.
    Zhou XH; Li LD; Wu LM; Wang W; Han L; Yang J; Qiao HX; Zhou XF
    Methods Find Exp Clin Pharmacol; 2007 May; 29(4):283-90. PubMed ID: 17609742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
    Dorati R; Genta I; Colzani B; Tripodo G; Conti B
    Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone reduces acute ischemic injury of the myocardium.
    Feola M; Crass MF
    Surg Gynecol Obstet; 1986 Dec; 163(6):523-30. PubMed ID: 3787426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery reperfusion. I. Early effects on local myocardial function and the extent of myocardial necrosis.
    Maroko PR; Libby P; Ginks WR; Bloor CM; Shell WE; Sobel BE; Ross J
    J Clin Invest; 1972 Oct; 51(10):2710-6. PubMed ID: 5056663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activity of total serum creatine phosphokinase and its MB fraction in reversible coronary blood flow disorders in dogs in a chronic experiment].
    Savchuk VI; Vinogradov AV; Pozin VM; Zhuravleva IA; Tumarkina KM
    Kardiologiia; 1980 Jan; 20(1):58-60. PubMed ID: 7354598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.